Cellular actions and pharmacology of the calcium channel blocking drugs

1985 ◽  
Vol 79 (4) ◽  
pp. 2-10 ◽  
Author(s):  
Arnold M. Katz ◽  
W.David Hager ◽  
Frank C. Messineo ◽  
Achilles J. Pappano
1996 ◽  
Vol 19 (3) ◽  
pp. 430-437 ◽  
Author(s):  
Shuji SHIMADA ◽  
Yukiko NAKAJIMA ◽  
Koujirou YAMAMOTO ◽  
Yasufumi SAWADA ◽  
Tatsuji IGA

2002 ◽  
Vol 61 (3) ◽  
pp. 649-658 ◽  
Author(s):  
P. Phani Kumar ◽  
Stephanie C. Stotz ◽  
R. Paramashivappa ◽  
Aaron M. Beedle ◽  
Gerald W. Zamponi ◽  
...  

1986 ◽  
Vol 31 (5) ◽  
pp. 442-444 ◽  
Author(s):  
Leigh Solomon ◽  
Peter Williamson

The authors report two cases of Bipolar Affective Disorder which were responsive to Lithium therapy in the past, but could no longer be treated with Lithium due to hyperparathyroidism in the first case and noncompliance in the second. In both cases, successful control of hypomania was achieved with Verapamil, but treatment of depression required the addition of Trazodone. The rationale for employing a calcium channel blocking agent, such as Verapamil, in bipolar illness is reviewed.


2020 ◽  
Vol 26 (4) ◽  
pp. 34-39
Author(s):  
Boris Borisovich Yatsinyuk ◽  
◽  
Pavel Pavlovich Gavrikov ◽  
Yulia Vasilyevna Lobur

The research of an analysis of the cardiac hemodynamic effects of an acute chemical trauma with slow calcium channels blockers (verapamil) shows that the depth of disorder of cardiac hemodynamic parameters and the level and frequency of occurrence of consciousness disorder were determined in 46 patients within the period of 2007–2017 in this nosological form of acute poisoning.


Sign in / Sign up

Export Citation Format

Share Document